| Product Name | MF | CAS | Details |
|---|
| Vildagliptin Impurity 1/Vildagliptin Diketo Impurity/Vildagliptin Lactam/2-((1r,3s,5R,7S)-3-hydroxyadamantan-1-yl)hexahydropyrrolo[1,2-a]pyrazine-1,4-dione | C17H24N2O3 | 1789703-36-1 | Details |
| Rabeprazole impurity 2/Rabeprazole EP Impurity D/2-(((1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-4-(3-methoxypropoxy)-3-methylpyridine 1-oxide | C18H21N3O4S | 924663-38-7 | Details |
| Omeprazole impurity 4/Omeprazole EP Impurity D/Omeprazole Sulfone/5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphonyl]-1H-benzimidazole | C17H19N3O4S | 88546-55-8 | Details |
| Omeprazole impurity 3/Omeprazole EP Impurity B/4-Desmethoxy Omeprazole/2-[(RS)-[(3,5-Dimethylpyridin-2-yl)methyl]sulphinyl]-5-methoxy-1H-benzimidazole | C16H17N3O2S | 110374-16-8 | Details |
| Prasugrel impurity 4/Prasugrel Chlorobutyryl Analog/5-(5-chloro-1-(2-fluorophenyl)-2-oxopentyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate | C20H21ClFNO3S | 1056459-37-0 | Details |
| Selexipag impurity 3/2,3-dichloro-5,6-diphenylpyrazine | C16H10Cl2N2 | 57038-62-7 | Details |
| Vildagliptin Impurity 9/(S)-1-(2-Chloro-acetyl)-pyrrolidine-2-carboxylic acid | C7H10ClNO3 | 23500-10-9 | Details |
| Rabeprazole impurity 15/(S)-O-Desmethyl Rabeprazole Impurity/(S)-3-((2-(((1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-3-methylpyridin-4-yl)oxy)propan-1-ol | C17H19N3O3S | 179952-05-7 | Details |
| Vildagliptin Impurity 14/(R)-Vildagliptin/(R)-1-(((1r,3S,5R,7S)-3-hydroxyadamantan-1-yl)glycyl)pyrrolidine-2-carbonitrile | C17H25N3O2 | 1036959-27-9 | Details |
| Omeprazole impurity 9/Omeprazole EP Impurity I/Omeprazole Sulfone N-Oxide/5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphonyl]-1H-benzimidazole N-Oxide | C17H19N3O5S | 158812-85-2 | Details |
| Vortioxetine impurity 2/1-CHLORO-2-NITROSO-BENZENE | C6H4ClNO | 932-33-2 | Details |
| Tedizolid impurity 10/(S)-Tedizolid/(S)-3-(3-fluoro-4-(6-(2-Methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)-5-(hydroxyMethyl)oxazolidin-2-one | C17H15FN6O3 | 1431699-67-0 | Details |
| Parecoxib impurity 1/N-((3-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide | C19H18N2O4S | 1709956-89-7 | Details |
| Levosimendan impurity 6/Acetamide,N-[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-, (R)- | 39052-02-1 | Details |
| Tedizolid impurity 13/(S)-(3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl) phenyl)-2-oxooxazolidin-5-yl)methyl dihydrogen phosphate | C17H16FN6O6P | 1835340-19-6 | Details |
| Tedizolid impurity 11/6,6'-bis(2-methyl-2H-tetrazol-5-yl)-3,3'-bipyridine | C14H12N10 | 2095840-91-6 | Details |
| Vortioxetine impurity 3/N-(2-chlorophenyl)hydroxylamine | C6H6ClNO | 10468-16-3 | Details |
| Vortioxetine impurity 1/N,N-Dimethyl-2-nitroaniline | C8H10N2O2 | 610-17-3 | Details |
| Tedizolid impurity 14/Diphosphoric acid P,P'-bis[[(5R)-3-[3-fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl] ester | C34H30F2N12O11P2 | 1220910-90-6 | Details |
| Tedizolid impurity 12/(R)-5-(chloromethyl)-3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)oxazolidin-2-one | C17H14ClFN6O2 | 1239662-46-4 | Details |
| Racecadotril impurity 6/Racecadotril EP Imurity H/dibenzyl 5,10-dibenzyl-4,11-dioxo-7,8-dithia-3,12-diazatetradecanedioate | C38H40N2O6S2 | 141437-88-9 | Details |
| Cimetidine impurity 9/Cimetidine EP Impurity I HCl/(5-ethyl-1H-imidazol-4-yl)methanol hydrochloride | C6H10N2O | 38603-74-6 | Details |
| Cimetidine impurity 10/Cimetidine EP Impurity J DiHCl/2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethan-1-amine dihydrochloride | C7H15Cl2N3S | 38603-72-4 | Details |
| Cimetidine impurity 5/Cimetidine EP Impurity E/Cimetidine Sulfoxide /2-Cyano-1-methyl-3-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulfinyl]-ethyl]guanidine ; | C10H16N6OS | 54237-72-8 | Details |
| Cimetidine impurity 3/Cimetidine EP Impurity C/Cimetidine Amide Impurity/1-[(Methylamino)-[[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl]-ethyl] amino]methylidene]urea | C10H18N6OS | 77076-18-7 | Details |
| Racecadotril impurity 4/Racecadotril EP Imurity F/benzyl [(2-benzylprop-2-enoyl)amino]acetate | C19H19NO3 | 87428-99-7 | Details |
| Racecadotril impurity 2/Racecadotril EP impurity C/[[(2RS)-2-[(acetylsulfanyl)methyl]-3-phenylpropanoyl]amino]acetic acid | C14H17NO4S | 124735-06-4 | Details |
| Racecadotril impurity 7/Racecadotril Diacid Impurity/3,3-Disulfanediylbis(2-benzylpropanoic acid) | C20H22O4S2 | 141437-87-8 | Details |
| Racecadotril impurity 3/Racecadotril EP impurity D/5,10-dibenzyl-4,11-dioxo-7,8-dithia-3,12-diazatetradecanedioic acid | C24H28N2O6S2 | 123658-06-0 | Details |
| ZolpidemEPImpurityA | C19H21N3O | 1346600-85-8 | Details |
| Rupatadine impurity 1/Rupatadine N-Oxide/3-((4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidin-1-yl)methyl)-5-methylpyridine 1-oxide | C26H26ClN3O | 1704730-21-1 | Details |
| Sorafenib impurity 2/Deschloro Sorafenib/N-Methyl-4-[4-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-2-pyridinecarboxamide | C21H17F3N4O3 | 1285533-84-7 | Details |
| SafinamideAcid | C17H18FNO3 | 1160513-60-9 | Details |
| Safinamide impurity 1/(S)-2-((4-(benzyloxy)benzyl)amino)propanamide | C17H20N2O2 | 133865-32-4 | Details |
| Safinamide impurity 5/(S)-2-((3-((3-fluorobenzyl)oxy)benzyl)amino)propanamide | C17H19FN2O2 | 861398-52-9 | Details |
| Erlotinib impurity 7/Erlotinib Carboxylic Acid/-(3-((6,7-bis(2-methoxyethoxy)quinazolin-4-yl)amino)phenyl)acetic acid | C22H25N3O6 | 882420-21-5 | Details |
| Erlotinib impurity 10/N-(3-bromophenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine | C20H22BrN3O4 | 328528-74-1 | Details |
| Erlotinib impurity 21/6-(2-chloroethoxy)-N-(3-ethynylphenyl)-7-(2-methoxyethoxy)quinazolin-4-amine | C21H20ClN3O3 | 183321-83-7 | Details |
| Sorafenib impurity 13/Sorafenib Urea Impurity/N-methyl-4-(4-ureidophenoxy)picolinamide | C14H14N4O3 | 1129683-88-0 | Details |
| Vildagliptin Impurity 20 | C19H27F3N2O6 | 565453-41-0 | Details |
| Sorafenib impurity 1/ethyl (4-chloro-3-(trifluoromethyl)phenyl)carbamate | C10H9ClF3NO2 | 18585-06-3 | Details |
| Sorafenib impurity 7/Methyl 4-(Methylamino)picolinate | C8H10N2O2 | 1256817-30-7 | Details |
| Sorafenib impurity 8/1-(4-Chloro-3-(trifluoromethyl)phenyl)urea | C8H6ClF3N2O | 343247-69-8 | Details |
| Omeprazole impurity 11/Omeprazole N-Methyl 5-Methoxy Analog/5-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1-methyl-1H-benzo[d]imidazole | C18H21N3O3S | 89352-76-1 | Details |
| Sorafenib impurity 5/6-Chloro-N-methylpyridine-2-carboxamide | C7H7ClN2O | 845306-04-9 | Details |
| Fasudil impurity 9/N,N'-Bis(ethylene)-p-Toluenesulfonamide | C16H20N2O4S2 | 4403-78-5 | Details |
| Prasugrel impurity 2/Prasugrel Para-Fluoro Isomer/5-(2-cyclopropyl-1-(4-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate | C20H20FNO3S | 1391194-50-5 | Details |
| Vildagliptin Impurity 16/Vildagliptin Chloroacetyl Nitrile (S)-Isomer/(2S)-1-(Chloroacetyl)-2-Pyrrolidinecarbonitrile | C7H9ClN2O | 207557-35-5 | Details |
| Rabeprazole impurity 16/(R)-O-Desmethyl Rabeprazole Impurity/(R)-3-((2-(((1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-3-methylpyridin-4-yl)oxy)propan-1-ol | C17H19N3O3S | 179952-04-6 | Details |
| Rabeprazole impurity 8/2-(((4-(3-chloropropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole | C17H18ClN3O2S | 1613482-73-7 | Details |
| Rabeprazole impurity 4/Rabeprazole EP Impurity G/Rabeprazole Sulfide 4-Methoxy Analog/2-[[(4-Methoxy-3-methyl-2-pyridinyl)methyl]sulfanyl]-1H-benzimidazole | C15H15N3OS | 102804-82-0 | Details |
| Safinamide impurity 2/(S)-2-((4-((4-fluorobenzyl)oxy)benzyl)amino)propanamide | C17H19FN2O2 | 202825-43-2 | Details |
| Safinamide impurity 3/(S)-2-((4-((2-fluorobenzyl)oxy)benzyl)amino)propanamide | C17H19FN2O2 | 133865-88-0 | Details |
| Rabeprazole impurity 6/Rabeprazole EP Impurity I/Rabeprazole Sulfone N-Oxide/2-[[[4-(3-Methoxypropoxy)-3-methyl-1-oxido-2-pyridinyl] methyl]sulfonyl]-1H-benzimidazole | C18H21N3O5S | 924663-37-6 | Details |
| Omeprazole impurity 5/Omeprazole EP Impurity E/Omeprazole N-Oxide/4-Methoxy-2-[[(RS)-(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-3,5-dimethylpyridine 1-oxide | C17H19N3O4S | 176219-04-8 | Details |
| Omeprazole impurity 17/5-Methoxy-1H-benzimidazole-2-sulfonic acid | C8H8N2O4S | 106135-28-8 | Details |
| Prasugrel impurity 3/5-(2-cyclopropyl-2-oxo-1-phenylethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate | C20H21NO3S | 1391194-45-8 | Details |
| Vildagliptin Impurity 3/Vildagliptin Mono Keto Impurity/Hexahydro-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-1-imino- pyrrolo[1,2-a]pyraz | C17H25N3O2 | 1789703-37-2 | Details |
| Vildagliptin Impurity 6/Vildagliptin Dimer Impurity/(2S,2S)-1,1-[[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)imino]bis(1-oxo-2,1-ethanediyl)]bis[2-Pyrrolidinecarbonitrile] | C24H33N5O3 | 1036959-23-5 | Details |
| Vildagliptin Impurity 8/Vildagliptin Chloroacetyl Amide (S)-Isomer/(S)-1-(2-chloroacetyl)pyrrolidine-2-carboxamide | C7H11ClN2O2 | 214398-99-9 | Details |
| Vildagliptin Impurity 13/((1r,3s,5R,7S)-3-hydroxyadamantan-1-yl)glycine | C12H19NO3 | 1032564-18-3 | Details |
| Vildagliptin Impurity 17/Vildagliptin Dipyrrolidine Impurity/octahydro-5H,10H-dipyrrolo[1,2-a:1',2'-d]pyrazine-5,10-dione | C10H14N2O2 | 6708-06-1 | Details |
| Vildagliptin Impurity 15/Vildagliptin Chloroacetyl Nitrile (R)-Isomer/(1S)-2-(2-chloroacetyl)cyclopentane-1-carbonitrile | C7H9ClN2O | 565452-98-4 | Details |
| Prasugrel impurity 1/5-(2-Cyclopropyl-1-(3-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate | C20H20FNO3S | 1391194-39-0 | Details |
| Fasudil impurity 10 | C19H24N2O4S2 | 5769-35-7 | Details |
| Palbociclib impurity 1/1-(2-Chloro-4-(cyclopentylamino)pyrimidin-5-yl)ethan-1-one | C11H14ClN3O | 1244949-62-9 | Details |
| Sorafenib impurity 20/Sorafenib Hydroxydemethylamine/4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-2-pyridinecarboxylic Acid | C20H13ClF3N3O4 | 1012058-78-4 | Details |
| Sorafenib impurity 4/4-Deschloro-2-chloro-Sorafenib/4-(4-(3-(2-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide | C21H16ClF3N4O3 | 1431697-81-2 | Details |
| SafinamideImpurity7 | C14H13FO2 | 690969-16-5 | Details |
| Erlotinib impurity 6/Erlotinib Hydroxy Metabolite/4-Hydroxy Erlotinib/4-((6,7-bis(2-methoxyethoxy)quinazolin-4-yl)amino)-2-ethynylphenol | C22H23N3O5 | 882420-22-6 | Details |
| Sorafenib impurity 23/Sorafenib N-Oxide/4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-2-(methylcarbamoyl)pyridine 1-oxide | C21H16ClF3N4O4 | 583840-03-3 | Details |
| Erlotinib impurity 20/7-O-Desmethoxy-7-O-chloroethyl Erlotinib/7-(2-chloroethoxy)-N-(3-ethynylphenyl)-6-(2-methoxyethoxy)quinazolin-4-amine | C21H20ClN3O3 | 183321-85-9 | Details |
| Safinamide impurity 9/(S)-2-[3-(2-fluoro-benzyl)-4-(2-fluoro-benzyloxy)-benzylamino]propanamide | C24H24F2N2O2 | 1000370-28-4 | Details |
| Vildagliptin Impurity 5/Vildagliptin Carboxylic Acid/(2s)-1-(2-((3-hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carboxylic acid | C17H26N2O4 | 565453-40-9 | Details |
| Vildagliptin Impurity 7/Vildagliptin Amide Impurity/N-(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)glycyl-L-prolinamide | C17H27N3O3 | 565453-39-6 | Details |
| Tedizolid impurity 8/(S)-3-(4-bromo-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one | C10H9BrFNO3 | 1369530-77-7 | Details |
| Vildagliptin Impurity 10/Methyl (2S)-1-(2-chloroacetyl)pyrrolidine-2-carboxylate | C8H12ClNO3 | 38074-72-5 | Details |
| Fasudil impurity 1/Quinoline-5-sulfonic acid | C9H7NO3S | 23261-58-7 | Details |
| Selexipag impurity 6/Selexipag Acid/2-{4-[(5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino]butoxy}acetic acid | C25H29N3O3 | 475085-57-5 | Details |
| Sorafenib impurity 6/4-Chloro-N,N-dimethylpyridine-2-carboxamide | C8H9ClN2O | 114780-06-2 | Details |
| Omeprazole impurity 18/(R)-Omeprazole/(R)-5-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole | C17H19N3O3S | 119141-89-8 | Details |
| Rupatadine impurity 2/3,5-bis((4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidin-1-yl)methyl)pyridine | C45H43Cl2N5 | 1224515-72-3 | Details |
| Zolpidem impurity 2/N,N-dimethyl-2-(6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl)-2-oxoacetamide | C19H19N3O2 | 400038-68-8 | Details |
| LevothyroxineEPImpurityF | C21H13I6NO5 | 911661-90-0 | Details |
| Ibrutinib impurity 3/ 3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | C17H13N5O | 330786-24-8 | Details |
| Ibrutinib impurity 7/(R)-N-Desacryloyl N-Propionyl Ibrutinib/1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-1-propanone | C25H26N6O2 | 1839099-22-7 | Details |
| Ibrutinib impurity 5/(R)-tert-butyl 3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-piperidine-1-carboxylate | C27H30N6O3 | 1022150-11-3 | Details |
| Ibrutinib impurity 2/(S)-Ibrutinib/(S)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one | C25H24N6O2 | 936563-97-2 | Details |
| Flucofuron/1,3-Bis(4-chloro-3-(trifluoromethyl)phenyl)urea | C15H8Cl2F6N2O | 370-50-3 | Details |
| Topiroxostat impurity 4/4-Amino-3,5-bis(4-pyridyl)-1,2,4-triazole | C12H10N6 | 38634-05-8 | Details |
| 10-Formyl Folic Acid | C20H19N7O7 | 134-05-4 | Details |
| Safinamide impurity 7/(R)-2-((4-((3-fluorobenzyl)oxy)benzyl)amino)propanamide | C17H19FN2O2 | 174756-44-6 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 | ||||